This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| International Liver Congress | |
|---|---|
| Name | International Liver Congress |
| Status | Active |
| Genre | Medical conference |
| Frequency | Annual |
| Venue | Varies |
| Location | Varies |
| First | 1950s |
| Organizer | European Association for the Study of the Liver |
| Attendance | tens of thousands |
International Liver Congress
The International Liver Congress is an annual scientific meeting centered on hepatology that convenes clinicians, researchers, and industry representatives from around the world. The Congress brings together specialists in liver disease from organizations such as the European Association for the Study of the Liver, the World Health Organization, the Centers for Disease Control and Prevention, the National Institutes of Health, and multinational pharmaceutical companies. Sessions routinely feature collaborations among investigators from institutions like Cambridge University Hospitals NHS Foundation Trust, Mayo Clinic, Johns Hopkins Hospital, Karolinska University Hospital, and Mount Sinai Health System.
The Congress functions as a focal point for advances in hepatology, including topics addressed by speakers from Harvard Medical School, University of Oxford, Stanford University School of Medicine, Imperial College London, and University of Tokyo. Attendees include representatives from regulatory agencies such as the European Medicines Agency, the Food and Drug Administration, and research funders like the Wellcome Trust and the Bill & Melinda Gates Foundation. Industry participation often includes firms such as Roche, Gilead Sciences, AbbVie, Johnson & Johnson, and Novartis. The program aligns with translational priorities championed by academic centers including UCSF Medical Center, Massachusetts General Hospital, and The Royal Free Hospital.
The Congress evolved from earlier hepatology symposia influenced by pioneers associated with institutions like Charité – Universitätsmedizin Berlin, Hopital Beaujon, Scripps Research, and University College London Hospitals. Historical milestones discussed at meetings have referenced landmark work from researchers at Institut Pasteur, Weill Cornell Medicine, University of Pennsylvania Health System, and Addenbrooke's Hospital. Over decades the event has navigated public health challenges involving pathogens studied by teams at Institut Pasteur de Dakar, Pasteur Institute of Iran, Walter Reed Army Institute of Research, and global responses coordinated with UNICEF. Venues have included cities served by organizations like Fira de Barcelona, ExCeL London, Palais des Congrès de Paris, Messe Berlin, and Milan Convention Center.
The Congress is organized by the European Association for the Study of the Liver with leadership drawn from committees that include representatives from institutions such as Trinity College Dublin, University of Edinburgh, KU Leuven, University of Barcelona, and University of Amsterdam. Scientific committees coordinate peer review processes influenced by editorial boards of journals like The Lancet, The New England Journal of Medicine, Gastroenterology (journal), Hepatology (journal), and Journal of Hepatology. Governance interacts with professional bodies including the American Association for the Study of Liver Diseases, the Asian Pacific Association for the Study of the Liver, and national societies such as the British Society of Gastroenterology and the Deutsche Gesellschaft für Gastroenterologie. Funding and sponsorship policies follow guidance from groups like the Council for International Organizations of Medical Sciences and the International Committee of Medical Journal Editors.
Programs feature plenary lectures by investigators affiliated with Yale School of Medicine, Peking University Health Science Center, Seoul National University Hospital, King's College London, and University of Toronto. Sessions include symposia on antiviral therapy referencing trials by teams at National Institute for Clinical Excellence and network consortia such as the EASL-Clinical Research Network. Workshops cover topics from liver transplantation with contributors from Cleveland Clinic, Toronto General Hospital, and Hôpital Saint-Luc to basic science presentations connected to laboratories at Cold Spring Harbor Laboratory, Max Planck Institute for Biology of Ageing, and Broad Institute. Clinical trial updates often cite investigators involved with multicenter studies like those coordinated by European Liver Transplant Registry and registries run by Transplantation Society.
Abstracts and studies presented at the Congress are frequently published in journals such as Journal of Hepatology, Hepatology (journal), The Lancet Gastroenterology & Hepatology, Clinical Infectious Diseases, and Nature Medicine. Collaborations highlighted at meetings have linked research groups from Dana-Farber Cancer Institute, Salk Institute, Fred Hutchinson Cancer Center, Institut Gustave Roussy, and Erasmus MC. Major randomized controlled trials presented have involved sponsors like GlaxoSmithKline, Bristol Myers Squibb, and academic trial networks including the European Clinical Research Infrastructure Network. Systematic reviews and meta-analyses discussed often reference data from Cochrane Collaboration and public health modeling from Imperial College London and Johns Hopkins Bloomberg School of Public Health.
Attendance attracts clinicians, scientists, trainees, and representatives from nonprofits including Médecins Sans Frontières, World Hepatitis Alliance, and patient advocacy groups like American Liver Foundation. The Congress influences clinical practice guidelines developed by bodies such as European Association for the Study of the Liver and adopted by national organizations like the American College of Physicians, Canadian Association for the Study of the Liver, and Australian Liver Association. Policy discussions at the meeting intersect with health agencies including the Department of Health and Social Care (UK), Ministry of Health (France), Federal Ministry of Health (Germany), and international entities like the World Bank when addressing global hepatitis elimination targets.
Notable sessions have announced breakthroughs in antiviral therapy with presentations from investigators at Gilead Sciences and AbbVie alongside academic partners from University of California San Diego, University of North Carolina at Chapel Hill, University of São Paulo, and Hospital Clinic Barcelona. Key outcomes include guideline updates coordinated with European Association for the Study of the Liver and policy briefings informing World Health Organization strategies. Other landmark moments linked to the Congress engaged stakeholders such as European Commission, United States Department of Health and Human Services, Bill & Melinda Gates Foundation, and trial consortia at National Cancer Institute.
Category:Hepatology conferences